Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
page
post

Obsessive Compulsive Disorder (OCD)

Clinical Pearls FAQs

How do I recognize and manage OCD?

OCD usually starts in two age groups: youth ages 7-12 and adolescents. However, OCD can occur across the lifespan and is common in children and adolescents. It is estimated that OCD affects around 0.5% of children and adolescents [2]. OCD is characterized by obsessions and/or compulsions that cause severe discomfort and interfere with functioning.

The criteria for diagnosis of OCD are as follows:

  • Presence of obsessions, compulsions, or both:
    • Obsessions
      • Recurrent and persistent thoughts that are intrusive and unwanted that cause individuals anxiety or distress
      • The individual attempts to ignore, neutralize, or suppress these thoughts with some other thought or action
    • Compulsions
      • Repetitive behaviors or mental acts the individual feels driven to perform
      • Behaviors/acts are aimed at preventing/reducing anxiety or a dreaded event or situation
      • Behaviors/acts are not connected in a realistic way or are clearly excessive
      • Obsessions are time consuming (more than 1 hour/day) or cause clinically significant distress/impairment in social, occupational, or other important areas of functioning

Some common themes of obsessions include but are not limited to:

  1. Contamination (fear/preoccupation with dirt, germs, illness)
  2. Harm (fear/preoccupation that something bad will happen to oneself or a loved one)
  3. Aggression/violence (thought/impulse to harm oneself or someone else)
  4. Recurrent doubt (fear/preoccupation on whether a task was completed correctly, e.g., “did I lock the door?”)
  5. Order (a need for things to be “just right” or arranged specifically, need for symmetry)
  6. Superstition (belief that certain actions/numbers can prevent bad events)
  7. Taboo or aggressive thoughts (fear/preoccupation of intrusive sexual or blasphemous thoughts, harming oneself, violent themes)
  8. Somatic (fear/preoccupation with internal bodily sensations, diet/weight, and/or health)

[3; 7; 10; 12]

Some common compulsive behaviors include but are not limited to:

  1. Washing/cleaning (excessive cleaning, bathing, and/or handwashing, not realistically connected to illness prevention)
  2. Checking (excessive checking of locks, homework, oven, body, light switches, etc., relieves anxiety or prevents feared event)
  3. Counting or repeating actions (repeatedly counting objects, performing actions, or reciting thoughts a specific number of times)
  4. Symmetry (excessive ordering/arranging objects until they are “just right”)
  5. Thought neutralization/reassurance (excessive confession of taboo thoughts, praying, repeating phrases or numbers, mental reviewing, or asking for reassurance to neutralize distressing thoughts or prevent something bad from happening)

[5; 7; 12; 15]

How is OCD commonly diagnosed and treated?

There are a few scales you can use as part of assessment, but in and of themselves are not completely diagnostic. In children, you can administer the CY-BOCS Checklist (Children’s Yale-Brown Obsessive Compulsive Scale) to ascertain current and past symptoms. You can use serial CY-BOCS severity rating scales to monitor patient progress [13]. For older adolescents and adults, you can administer the DOCS Dimensional Obsessive-Compulsive Scale. A total score >21 has about 70% sensitivity and 70% specificity in distinguishing OCD from other anxiety disorders [1].

Cognitive Behavioral Therapy (CBT) remains the first line treatment for OCD, specifically Exposure and Response Prevention (ERP). ERP systematically desensitizes the person by exposing them to situations that generate anxiety in a safe setting while preventing the patient from performing compulsions [14; 16]. For initial treatment of OCD, the efficacy in symptom reduction is equivalent between ERP and ERP+SSRI. ERP has been shown to be superior to SSRI monotherapy [14]. 

If CBT with ERP is ineffective or only partially effective after 13-20 sessions, or symptoms are particularly disabling, an SSRI can be added [11; 14]. Sertraline is approved for children 6 and older [18]. Fluoxetine and fluvoxamine are approved for children 8 and older [16; 17]. Paroxetine is approved for OCD in adults but not in children and should not be used in the pediatric populations [9]. Paroxetine typically should not be prescribed for youth under age 18 due to safety concerns surfaced by the FDA, American Academy of Child and Adolescent Psychiatry and other regulatory bodies relating to this medication being more activating, and having some potential for dependence and withdrawal with use. An adequate trial of SSRI is typically 8-12 weeks, of which 4-6 weeks should be at the maximum tolerable dose, before declaring treatment non-response. For the management of OCD with SSRIs, often doses at the higher end of the therapeutic range is needed to observe significant symptomatic relief and treatment response. 

Additionally, thoughtful psychoeducation and counseling play an important role in treating children and adolescents with OCD. Intrusive thoughts/obsessions in OCD are ego-dystonic, meaning that they do not align with the patient’s true feelings and values [4; 8]. It is this clash between a patient’s true feelings/opinions and these intrusive thoughts that makes them so distressing. Explaining this to patients can help them to understand that these thoughts are not related to underlying desires or moral failures, which can provide a lot of comfort. Additionally, it is important to provide counseling to family members to ensure that they do not unintentionally reinforce compulsive behaviors by participating in rituals (such as providing excessive reassurance). 

Abrams G, Malas N. Obsessive Compulsive Disorder. Michigan Clinical Consultation & Care. January 14, 2026. https://mc3michigan.org/clinical-pearls-faqs-obsessive-compulsive-disorder/.

References:

  1. Abramowitz JS, Deacon BJ, Olatunji BO, et al. Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale. Psychol Assess. 2010;22(1):180-198. doi:10.1037/a0018260
  2. American Academy of Child and Adolescent Psychiatry. Obsessive‑Compulsive Disorder in Children and Adolescents: Facts for Families Guide No 60. Updated October 2023. AACAP. Accessed August 3, 2025.
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; 2013:235-238.
  4. Audet JS, Bourguignon L, Aardema F. What makes an obsession? A systematic-review and meta-analysis on the specific characteristics of intrusive cognitions in OCD in comparison with other clinical and non-clinical populations. Clin Psychol Psychother. 2023 Nov-Dec;30(6):1446-1463. doi: 10.1002/cpp.2887. Epub 2023 Jul 22. PMID: 37482945.
  5. Barzilay R, Patrick A, Calkins ME, et al. Obsessive-Compulsive Symptomatology in Community Youth: Typical Development or a Red Flag for Psychopathology?. J Am Acad Child Adolesc Psychiatry. 2019;58(2):277-286.e4. doi:10.1016/j.jaac.2018.06.038
  6. Dougherty DD, Brennan BP, Stewart SE, Wilhelm S, Widge AS, Rauch SL. Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review. JAMA Psychiatry. 2018 Oct 1;75(10):1081-1087. doi:10.1001/jamapsychiatry.2018.0930.
  7. García-Soriano G, Carrasco Á, Emerson LM. Obsessional intrusive thoughts in children: An interview based study. Psychol Psychother. 2023;96(1):249-262. doi:10.1111/papt.12437
  8. Grant JE. Obsessive-compulsive disorder. N Engl J Med. 2014 Aug 14;371(7):646-653. doi:10.1056/NEJMcp1402176.
  9. Geller DA, Wagner KD, Emslie G, et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2004;43(11):1387-1396. doi:10.1097/01.chi.0000138356.29099.f1
  10. Ivarsson T, Valderhaug R. Symptom patterns in children and adolescents with obsessive-compulsive disorder (OCD). Behav Res Ther. 2006;44(8):1105-1116. doi:10.1016/j.brat.2005.08.008
  11. Kotapati VP, Khan AM, Dar S, Begum G, Bachu R, Adnan M, Zubair A, Ahmed RA. The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis. Front Psychiatry. 2019 Aug 6;10:523. doi: 10.3389/fpsyt.2019.00523. PMID: 31447707; PMCID: PMC6691487.
  12. Porth R, Geller D. Atypical symptom presentations in children and adolescents with obsessive compulsive disorder. Compr Psychiatry. 2018;86:25-30. doi:10.1016/j.comppsych.2018.07.006
  13. Scahill L, Riddle MA, McSwiggin‑Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF. Children’s Yale‑Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):844–852. doi:10.1097/00004583‑199706000‑00023
  14. Steele DW, Kanaan G, Caputo EL, Freeman JB, Brannan EH, Balk EM, Trikalinos TA, Adam GP. Treatment of Obsessive-Compulsive Disorder in Children and Youth: A Meta-Analysis. Pediatrics. 2024 Dec 6. doi: 10.1542/peds.2024-068992. Epub ahead of print. PMID: 39639456.
  15. Toro J, Cervera M, Osejo E, Salamero M. Obsessive-compulsive disorder in childhood and adolescence: a clinical study. J Child Psychol Psychiatry. 1992 Sep;33(6):1025-37. doi: 10.1111/j.1469-7610.1992.tb00923.x. PMID: 1400685.
  16. Uhre CF, Uhre VF, Lønfeldt NN, Pretzmann L, Vangkilde S, Plessen KJ, Gluud C, Jakobsen JC, Pagsberg AK. Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):64-77. doi: 10.1016/j.jaac.2019.08.480. Epub 2019 Oct 4. PMID: 31589909.
  17. U.S. National Library of Medicine. Fluoxetine [package insert]. DailyMed. Updated July 2023.
  18. U.S. National Library of Medicine. Fluvoxamine [package insert]. DailyMed. Updated July 2023.
  19. U.S. National Library of Medicine. Sertraline Hydrochloride [package insert]. DailyMed. Updated May 2023.